TW200621694A - Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds - Google Patents
Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compoundsInfo
- Publication number
- TW200621694A TW200621694A TW094139315A TW94139315A TW200621694A TW 200621694 A TW200621694 A TW 200621694A TW 094139315 A TW094139315 A TW 094139315A TW 94139315 A TW94139315 A TW 94139315A TW 200621694 A TW200621694 A TW 200621694A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- alkoxy
- alkyl group
- hydroxy
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62655904P | 2004-11-10 | 2004-11-10 | |
US66097805P | 2005-03-10 | 2005-03-10 | |
US69980105P | 2005-07-15 | 2005-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200621694A true TW200621694A (en) | 2006-07-01 |
Family
ID=35457662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094139315A TW200621694A (en) | 2004-11-10 | 2005-11-09 | Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1824837B1 (zh) |
JP (1) | JP4799562B2 (zh) |
KR (1) | KR20070085957A (zh) |
AR (1) | AR051952A1 (zh) |
AT (1) | ATE404546T1 (zh) |
AU (1) | AU2005303492A1 (zh) |
BR (1) | BRPI0517740A (zh) |
CA (1) | CA2587149C (zh) |
DE (1) | DE602005009017D1 (zh) |
EA (1) | EA200701035A1 (zh) |
ES (1) | ES2308562T3 (zh) |
GT (1) | GT200500323A (zh) |
IL (1) | IL183043A0 (zh) |
MA (1) | MA29012B1 (zh) |
MX (1) | MX2007005709A (zh) |
NL (1) | NL1030382C2 (zh) |
NO (1) | NO20072409L (zh) |
PA (1) | PA8652301A1 (zh) |
PE (1) | PE20061049A1 (zh) |
TN (1) | TNSN07178A1 (zh) |
TW (1) | TW200621694A (zh) |
UY (1) | UY29197A1 (zh) |
WO (1) | WO2006051378A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI743210B (zh) * | 2016-09-28 | 2021-10-21 | 韓商愛茉莉太平洋股份有限公司 | 用於製造(r)-n-[4-(1-胺乙基)-2,6-二氟苯基]甲烷磺胺之方法 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1857440A1 (en) * | 2006-04-19 | 2007-11-21 | Amorepacific Corporation | Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
CA2656875C (en) | 2006-07-11 | 2011-09-06 | Pfizer Inc. | Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
AR063211A1 (es) | 2006-07-27 | 2009-01-14 | Amorepacific Corp | Derivados de 3-(piridin-3-il)acrilamida y 3-(piridin-3-il)propionamida, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con el receptor vaniloide. |
ES2349066T3 (es) | 2006-09-15 | 2010-12-22 | Pfizer Inc. | Compuestos de piridilmetilbiciclocarboxamida sustituida. |
JP2010512305A (ja) | 2006-10-23 | 2010-04-22 | ファイザー株式会社 | 置換フェニルメチルビシクロカルボキシアミド化合物 |
KR101619341B1 (ko) | 2008-01-28 | 2016-05-11 | (주)아모레퍼시픽 | 바닐로이드 수용체 길항체로서의 신규 화합물, 이의 이성질체 또는 약제학적으로 허용가능한 염, 및 이를 함유하는 약학 조성물 |
CN102137851B (zh) | 2008-07-02 | 2014-08-27 | 株式会社爱茉莉太平洋 | 作为香草素受体拮抗剂的化合物、其异构体或其药学可接受的盐以及包含它们的药物组合物 |
CN102234287B (zh) | 2010-04-26 | 2015-08-05 | 上海阳帆医药科技有限公司 | 硝基咪唑类化合物、其制备方法和用途 |
PE20131095A1 (es) | 2010-07-16 | 2013-10-27 | Abbvie Bahamas Ltd | Ligandos fosfina para reacciones cataliticas |
US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
JP5819959B2 (ja) | 2010-07-16 | 2015-11-24 | アッヴィ・バハマズ・リミテッド | 抗ウイルス性化合物を調製するための方法 |
US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
AR089771A1 (es) * | 2012-01-31 | 2014-09-17 | Lilly Co Eli | Derivados de bencil sulfonamida utiles como inhibidores de mogat-2 |
TWI805601B (zh) | 2017-08-11 | 2023-06-21 | 南韓商愛茉莉太平洋股份有限公司 | 醫藥組成物及抑制其形成結晶的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60120421T2 (de) * | 2000-08-21 | 2006-12-28 | Pacific Corp. | Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten |
AU8022901A (en) * | 2000-08-21 | 2002-03-04 | Pacific Corp | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
GB0105895D0 (en) * | 2001-03-09 | 2001-04-25 | Smithkline Beecham Plc | Novel compounds |
JP2003192660A (ja) * | 2001-12-26 | 2003-07-09 | Bayer Ag | 尿素誘導体 |
KR100556158B1 (ko) * | 2002-10-17 | 2006-03-06 | (주) 디지탈바이오텍 | 신규 엔-하이드록시 티오우레아, 우레아 및 아미드계화합물 및 이를 함유하는 약제학적 조성물 |
KR100707123B1 (ko) * | 2003-07-02 | 2007-04-16 | 그뤼넨탈 게엠베하 | 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물 |
-
2005
- 2005-10-31 EA EA200701035A patent/EA200701035A1/ru unknown
- 2005-10-31 CA CA002587149A patent/CA2587149C/en not_active Expired - Fee Related
- 2005-10-31 BR BRPI0517740-5A patent/BRPI0517740A/pt not_active Application Discontinuation
- 2005-10-31 KR KR1020077013011A patent/KR20070085957A/ko not_active Application Discontinuation
- 2005-10-31 MX MX2007005709A patent/MX2007005709A/es not_active Application Discontinuation
- 2005-10-31 WO PCT/IB2005/003321 patent/WO2006051378A1/en active IP Right Grant
- 2005-10-31 AT AT05797364T patent/ATE404546T1/de not_active IP Right Cessation
- 2005-10-31 ES ES05797364T patent/ES2308562T3/es active Active
- 2005-10-31 EP EP05797364A patent/EP1824837B1/en not_active Not-in-force
- 2005-10-31 AU AU2005303492A patent/AU2005303492A1/en not_active Abandoned
- 2005-10-31 DE DE602005009017T patent/DE602005009017D1/de active Active
- 2005-10-31 JP JP2007540735A patent/JP4799562B2/ja not_active Expired - Fee Related
- 2005-11-08 PE PE2005001307A patent/PE20061049A1/es not_active Application Discontinuation
- 2005-11-08 GT GT200500323A patent/GT200500323A/es unknown
- 2005-11-08 UY UY29197A patent/UY29197A1/es not_active Application Discontinuation
- 2005-11-09 AR ARP050104702A patent/AR051952A1/es unknown
- 2005-11-09 PA PA20058652301A patent/PA8652301A1/es unknown
- 2005-11-09 NL NL1030382A patent/NL1030382C2/nl not_active IP Right Cessation
- 2005-11-09 TW TW094139315A patent/TW200621694A/zh unknown
-
2007
- 2007-05-07 IL IL183043A patent/IL183043A0/en unknown
- 2007-05-09 TN TNP2007000178A patent/TNSN07178A1/fr unknown
- 2007-05-09 NO NO20072409A patent/NO20072409L/no not_active Application Discontinuation
- 2007-05-10 MA MA29885A patent/MA29012B1/fr unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI743210B (zh) * | 2016-09-28 | 2021-10-21 | 韓商愛茉莉太平洋股份有限公司 | 用於製造(r)-n-[4-(1-胺乙基)-2,6-二氟苯基]甲烷磺胺之方法 |
Also Published As
Publication number | Publication date |
---|---|
NL1030382A1 (nl) | 2006-05-11 |
JP4799562B2 (ja) | 2011-10-26 |
GT200500323A (es) | 2006-09-11 |
NO20072409L (no) | 2007-06-11 |
PE20061049A1 (es) | 2006-10-26 |
EP1824837A1 (en) | 2007-08-29 |
AU2005303492A1 (en) | 2006-05-18 |
ATE404546T1 (de) | 2008-08-15 |
EA200701035A1 (ru) | 2007-10-26 |
MX2007005709A (es) | 2007-07-09 |
EP1824837B1 (en) | 2008-08-13 |
CA2587149A1 (en) | 2006-05-18 |
DE602005009017D1 (de) | 2008-09-25 |
ES2308562T3 (es) | 2008-12-01 |
NL1030382C2 (nl) | 2006-11-21 |
TNSN07178A1 (fr) | 2008-11-21 |
PA8652301A1 (es) | 2006-09-22 |
MA29012B1 (fr) | 2007-11-01 |
WO2006051378A1 (en) | 2006-05-18 |
KR20070085957A (ko) | 2007-08-27 |
IL183043A0 (en) | 2007-09-20 |
AR051952A1 (es) | 2007-02-21 |
CA2587149C (en) | 2010-02-02 |
JP2008519817A (ja) | 2008-06-12 |
BRPI0517740A (pt) | 2008-10-21 |
UY29197A1 (es) | 2006-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200621694A (en) | Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds | |
TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
TW200700398A (en) | Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds | |
TW200604175A (en) | Ortho substituted aryl or heteroaryl amide compounds | |
MX2009005449A (es) | Compuesto heteromonociclico y uso del mismo. | |
WO2005105732A8 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
TW200726470A (en) | 6,7-unsaturated-7-carbamoylmorphinan derivatives | |
RS20050732A (en) | Substituted pyrimidinones | |
AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
DE602007008550D1 (de) | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung | |
TW200744587A (en) | Azaindole derivatives exhibiting PGD2 receptor antagonism | |
TW200517109A (en) | Substituted pyridinones | |
TW200519088A (en) | Aryl or heteroaryl amide compounds | |
MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
SI1786790T1 (sl) | Derivati oksazola kot agenti histamin h3 receptorja, priprava in terapevtska uporaba | |
TW200612920A (en) | Novel imidazolidine derivatives | |
NO20062617L (no) | Anvendelse av glukosidase inhibitorer for terapi av mucovisidose | |
TW200637539A (en) | CTGF inhibitors | |
MXPA05010824A (es) | Compuestos biciclicos como antagonistas del receptor nr2b. | |
AR064253A1 (es) | Compuestos de biciclocarboxiamida sustituidos composiciones farmaceuticas y una combinacion que los incluye y su uso en fabaricacion de un medicamento para el tratamiento de enfermedades mediadas por la actividad del receptor vr1 | |
MX2010006882A (es) | Derivado novedoso de catecol, composición farmaceutica que contiene el mismo, uso del derivado de catecol, y uso de la composición farmaceutica. | |
TW200637552A (en) | Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases | |
MX2011009746A (es) | Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica. | |
DE602006013828D1 (en) | 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren | |
TW200621227A (en) | Medicament for preventing or treating fatty liver |